Inflammation induces fibrinogen nitration in experimental human endotoxemia

Free Radical Biology and Medicine

Volumn 47, Issue 8, 2009, Pages 1140-1146

  Heffron, Sean P ^a   Parastatidis, Ioannis ^b   Cuchel, Marina ^a   Wolfe, Megan L ^a   Tadesse, Mahlet G ^c   Mohler III, Emille R ^a   Ischiropoulos, Harry ^b   Rader, Daniel J ^a   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Coronary artery calcification; Fibrinogen; High density lipoprotein (HDL); Intima medial thickness; Nitration

Indexed keywords

3 NITROTYROSINE; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MALE; NITRATION; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CALCINOSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHOLESTEROL, HDL; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUNICA INTIMA; YOUNG ADULT;

EID: 70249143888     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.025     Document Type: Article

References (34)

1. Maresca G., Di Blasio A., Marchioli R., and Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1368-1377
2. Parastatidis I., Thomson L., Fries D.M., Moore R.E., Tohyama J., Fu X., Hazen S.L., Heijnen H.F., Dennehy M.K., Liebler D.C., Rader D.J., and Ischiropoulos H. Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I-deficient mice. Circ. Res. 101 (2007) 368-376
3. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 256 (1986) 2835-2838
4. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheun M.C., Byun J., Vuletic S., Kassim S., Singh P., Chea H., Knopp R.H., Brunzell J., Geary R., Chait A., Zhao X.Q., Elkon K., Marcovina S., Ridker P., Oram J.F., and Heinecke J.W. Shotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDL. J. Clin. Invest. 117 (2007) 746-756
5. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340 (1999) 14-22
6. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., and Schwartz R.S. Coronary artery calcium areas by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 92 (1995) 2157-2162
7. Kondos G.T., Hoff J.A., Sevrukov A., Daviglus M.L., Garside D.B., Devries S.S., Chomka E.V., and Liu K. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107 (2003) 2571-2576
8. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
9. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15 (1990) 827-832
10. Reilly M.P., Wolfe M.L., Localio A.R., and Rader D.J. Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach. Atherosclerosis. 173 (2004) 69-78
11. Anderson P.D., Mehta N.N., Wolfe M.L., Hinkle C.C., Pruscino L., Comiskey L.L., Tabita-Martinez J., Sellers K.F., Rickels M.R., Ahima R.S., and Reilly M.P. Innate immunity modulates adipokines in humans. J. Clin. Endocrinol. Metab. 92 (2007) 2272-2279
12. Heijnen H.F., van Donselaar E., Slot J.W., Fries D.M., Blachard-Fillion B., Hodara R., Lightfoot R., Polydoro M., Spielberg D., Thomson L., Regan E.A., Crapo J., and Ischiropoulos H. Subcellular localization of tyrosine-nitrated proteins is dictated by reactive oxygen species generating enzymes and by proximity to nitric oxide synthase. Free Radic. Biol. Med. 40 (2006) 1903-1913
13. Ischiropoulos H., Zhu L., Chen J., Tsai M., martin J.C., Smith C.D., and Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298 (1992) 431-437
14. Vadseth C., Souza J.M., Thomson L., Seagraves A., Nagaswami C., Scheiner T., Torbet J., Vilaire G., Bennett J.S., Murciano J.C., Muzykantov V., Penn M.S., Hazen S.L., Weisel J.W., and Ischiropoulos H. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J. Biol. Chem. 279 (2004) 8820-8826
15. Pleiner J., Heere-Ress E., Langenberger H., Sieder A.E., Bayerle-Eder M., Mittermayer F., Fuchsjager-Mayrl G., Bohm J., Jansen B., and Wolzt M. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 95-100
16. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
17. Pignatelli B., Li C.Q., Boffetta P., Chen Q., Ahrens W., Nyberg F., Mukeria A., Bruske-Hohlfeld I., Fortes C., Constantinescu V., Ischiropoulos H., and Ohshima H. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res. 61 (2001) 778-784
18. Gole M.D., Souza J.M., Choi I., Hertkorn C., Malcolm S., Foust 3rd R.F., Finkel B., Lanken P.N., and Ischiropoulos H. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (2000) L961-L967
19. Dedon P.C., and Tannenbaum S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 423 (2004) 12-22
20. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., Belaaouaj A., and Heinecke J.W. Myeloperoxidase produces nitrating oxidants in vivo. J. Clin. Invest. 109 (2002) 1311-1319
21. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., and Hazen S.L. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 277 (2002) 17415-17427
22. Inada Y., Hessel B., and Blombäck B. Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochim. Biophys. Acta 532 (1978) 161-170
23. Shacter E., Williams J.A., and Levine R.L. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic. Biol. Med. 18 (1995) 815-821
24. Navab M., Anantharamaiah G.M., and Fogelman A.M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15 (2005) 158-161
25. Baker P.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res. 40 (1990) 345-353
26. Rader D.J. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 92 (2003) 42J-49J
27. Navab M., Anantharamaiah G.M., and Fogelman A.M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15 (2005) 158-161
28. Mineo C., Deguchi H., Griffin J.H., and Shaul P.W. Endothelial and antithrombotic actions of HDL. Circ. Res. 98 (2006) 1352-1364
29. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney J.F., Penn M.S., Sprecher D.L., Vita J.A., and Hazen S.L. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289 (2003) 1675-1680
30. In: Kumar V., Cotran R.S., and Robbins S.L. (Eds). Robbins Basic Pathology. 7th ed (2003), Saunders, Philadelphia
31. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
32. Folsom A.R., Wu K.K., Shahar E., and Davis C.E. for the ARIC Study Investigation. Association of haemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler. Thromb. 13 (1993) 1829-1836
33. Tracy R.P., Bovill E.G., Yanez D., Psaty B.M., Fried L.P., Heiss G., Lee M., Polak J.F., and Savage P.J. for the Cardiovascular Health Study. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly: results from the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1269-1279
34. Ebrahim S., Papacosta O., Whincup P., Wannamethee G., Walker M., Nicolaides A.N., Dhanjil S., Griffin M., Belcaro G., Rumley A., and Lowe G.D. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 30 (1999) 841-850